Published in Hepatology on April 01, 2008
Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study. Hepatology (2014) 2.14
Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort. J Natl Cancer Inst (2010) 1.81
Underestimation of liver-related mortality in the United States. Gastroenterology (2013) 1.46
Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.33
Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol (2009) 1.16
Characteristics and management of patients with chronic hepatitis B in an integrated care setting. Dig Dis Sci (2014) 0.96
Alcohol-related and viral hepatitis C-related cirrhosis mortality among Hispanic subgroups in the United States, 2000-2004. Alcohol Clin Exp Res (2010) 0.95
Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years. Cancer (2014) 0.94
Hepatitis B screening and vaccination practices in asian american primary care. Gut Liver (2013) 0.89
Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems. Addiction (2013) 0.86
Mortality caused by chronic liver disease among American Indians and Alaska Natives in the United States, 1999-2009. Am J Public Health (2014) 0.85
Heavy alcohol use and premature death from hepatocellular carcinoma in the United States, 1999-2006. J Stud Alcohol Drugs (2011) 0.83
Descriptive epidemiology of chronic liver disease in northeastern Italy: an analysis of multiple causes of death. Popul Health Metr (2013) 0.83
Distinctly altered gut microbiota in the progression of liver disease. Oncotarget (2016) 0.82
Physical, social, and psychological consequences of treatment for hepatitis C : a community-based evaluation of patient-reported outcomes. Patient (2013) 0.79
Acute-on-chronic liver failure. Clin Liver Dis (2014) 0.79
Relationships among alcoholic liver disease, antioxidants, and antioxidant enzymes. World J Gastroenterol (2016) 0.78
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol (2006) 10.21
Telaprevir for previously treated chronic HCV infection. N Engl J Med (2010) 8.33
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep (2005) 5.70
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep (2006) 5.63
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
Ebola 2014--new challenges, new global response and responsibility. N Engl J Med (2014) 5.23
Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev (2006) 5.13
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology (2006) 4.90
Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med (2007) 4.69
A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol (2005) 4.48
Burden of liver disease in the United States: summary of a workshop. Hepatology (2002) 4.00
An outbreak of hepatitis A associated with green onions. N Engl J Med (2005) 3.89
Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst (2004) 3.86
Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 3.77
HIV infection and the risk of cancers with and without a known infectious cause. AIDS (2009) 3.13
An interferon-free antiviral regimen for HCV after liver transplantation. N Engl J Med (2014) 3.04
Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology (2004) 2.78
Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology (2008) 2.66
Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology (2005) 2.63
Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology (2006) 2.62
Incidence of hepatitis A in the United States in the era of vaccination. JAMA (2005) 2.42
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model. Cancer (2014) 2.26
Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology (2005) 2.24
Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med (2002) 2.11
HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev (2011) 2.02
A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol (2006) 1.90
PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus. Liver Transpl (2011) 1.85
Hepatitis A in the era of vaccination. Epidemiol Rev (2006) 1.75
Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis (2009) 1.66
Effectiveness of telaprevir and boceprevir triple therapy for patients with hepatitis C virus infection in a large integrated care setting. Dig Dis Sci (2014) 1.63
Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health (2002) 1.61
Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2011) 1.59
Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination. J Infect Dis (2008) 1.57
Alcohol use and hepatitis C. Hepatology (2002) 1.55
Chronic liver disease mortality in the United States, 1990-1998. Hepatology (2004) 1.55
The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol (2008) 1.55
Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA). J Clin Microbiol (2004) 1.55
National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis (2008) 1.55
Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C. Liver Transpl (2012) 1.54
Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation (2003) 1.54
Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. Liver Transpl (2011) 1.52
Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001. Emerg Infect Dis (2002) 1.51
Population-based surveillance for acute liver failure. Am J Gastroenterol (2007) 1.51
Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med (2005) 1.43
Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006. Arch Intern Med (2011) 1.35
Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology (2009) 1.35
Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001. Emerg Infect Dis (2002) 1.34
Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology (2007) 1.31
Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics (2002) 1.30
Ongoing transmission of hepatitis B virus infection among inmates at a state correctional facility. Am J Public Health (2005) 1.28
Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology (2010) 1.28
Distribution of hepatitis C virus genotypes in a diverse US integrated health care population. J Med Virol (2012) 1.22
A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. Hepatology (2013) 1.21
Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J (2008) 1.20
Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection. Hepatology (2012) 1.20
Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study. Am J Gastroenterol (2009) 1.16
Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis (2008) 1.16
HIV infection and incidence of ischemic stroke. AIDS (2014) 1.15
Epidemiology of hepatitis B and hepatitis B virus infection in United States children. Pediatr Infect Dis J (2005) 1.14
Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg (2010) 1.13
Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr (2014) 1.13
Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics (2007) 1.13
New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl (2004) 1.11
The changing epidemiology and natural history of hepatitis C virus infection. Clin Liver Dis (2006) 1.11
Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics (2007) 1.10
Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology (2011) 1.09
Influence of cannabis use on severity of hepatitis C disease. Clin Gastroenterol Hepatol (2008) 1.08
Locally acquired hepatitis E virus infection, El Paso, Texas. J Med Virol (2006) 1.08
Identification of patients with hepatitis C virus infection in New Haven County primary care practices. J Clin Gastroenterol (2003) 1.08
Prevalence of infection with waterborne pathogens: a seroepidemiologic study in children 6-36 months old in San Juan Sacatepequez, Guatemala. Am J Trop Med Hyg (2004) 1.07
Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS (2012) 1.07
Hepatitis B vaccination coverage levels among healthcare workers in the United States, 2002-2003. Infect Control Hosp Epidemiol (2007) 1.06
Molecular epidemiology of foodborne hepatitis a outbreaks in the United States, 2003. J Infect Dis (2005) 1.06
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant (2005) 1.06
Hepatitis a molecular epidemiology in the United States, 1996-1997: sources of infection and implications of vaccination policy. J Infect Dis (2005) 1.06
Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care. J Acquir Immune Defic Syndr (2016) 1.05
The science behind preparing and responding to pandemic influenza: the lessons and limits of science. Clin Infect Dis (2011) 1.04
Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine (2004) 1.04
Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007. J Acquir Immune Defic Syndr (2010) 1.04
The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction. J Acquir Immune Defic Syndr (2012) 1.03
Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in. Liver Transpl (2015) 1.01
Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection. Clin Gastroenterol Hepatol (2008) 1.00
Management of hepatitis B in liver transplant recipients. J Viral Hepat (2007) 0.99
Parental knowledge, attitudes, and practices associated with not receiving hepatitis A vaccine in a demonstration project in Butte County, California. Pediatrics (2003) 0.99
HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons. AIDS (2011) 0.98
The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Pediatrics (2007) 0.97
Characteristics and management of patients with chronic hepatitis B in an integrated care setting. Dig Dis Sci (2014) 0.96
Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia. Pediatr Infect Dis J (2010) 0.96
Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr (2014) 0.94
Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies. J Infect Dis (2003) 0.94
Chronic liver disease among two American Indian patient populations in the southwestern United States, 2000-2003. J Clin Gastroenterol (2008) 0.94
Management of posttransplant hepatitis C infection. Curr Opin Organ Transplant (2010) 0.94
A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments. Infect Control Hosp Epidemiol (2004) 0.93
Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy. Liver Transpl (2011) 0.92
Sex and hepatitis C. Am J Gastroenterol (2005) 0.92
Hepatitis A 2004 vaccination in children: methods and findings of a survey in two states. Am J Prev Med (2007) 0.92
Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection. Gastroenterology (2013) 0.92
Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma. Liver Transpl (2012) 0.91
Seroprevalence of hepatitis A virus antibodies in the U.S.: results from the National Health and Nutrition Examination Survey. Public Health Rep (2011) 0.91